| Literature DB >> 24732207 |
Shahram Eisa-Beygi1, Marc Ekker2, Thomas W Moon2, R Loch Macdonald3, Xiao-Yan Wen4.
Abstract
The 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) is the rate-limiting enzyme in the biosynthesis of cholesterol and isoprenoids, which are substrates required for post-translational modification of signalling proteins that can potentially regulate various aspects of embryonic development. The HMGCR transcripts are detectable during early embryogenesis in both invertebrates and vertebrates, which suggests a conserved developmental requirement for mevalonate derivatives. Consistently, recent animal and in vitro studies have yielded valuable insights into potential morphogenic parameters that are modulated by HMGCR activity. These developmental end-points include brain and craniofacial morphogenesis, PGC migration and survival, myocardial epithelial migration and fusion, EC migration and survival, and vascular stabilization. By providing a synthesis of these studies, we hope that this review will highlight the need to comprehensively examine the entire suite of developmental processes regulated by HMGCR.Entities:
Keywords: Cholesterol; Development; HMGCR; Prenylation; Statins; Teratogenesis; Toxicity
Mesh:
Substances:
Year: 2014 PMID: 24732207 DOI: 10.1016/j.reprotox.2014.04.001
Source DB: PubMed Journal: Reprod Toxicol ISSN: 0890-6238 Impact factor: 3.143